JC
Therapeutic Areas
Amylyx Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AMX0035 (RELYVRIO/ALBRIOZA) | Amyotrophic Lateral Sclerosis (ALS) | Approved / Phase 3 |
| AMX0035 | Wolfram Syndrome | Phase 2 |
| Avexitide | Post-Bariatric Hypoglycemia (PBH) | Phase 3 |
| AMX0114 | Amyotrophic Lateral Sclerosis (ALS) | Phase 1 |
| AMX0318 | Post-Bariatric Hypoglycemia (PBH) & Other Rare Diseases | Preclinical |